2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Breast Neoplasms
3099
Neoplasms
2443
Carcinoma, Non-Small-Cell Lung
1867
Prostatic Neoplasms
1619
Colorectal Neoplasms
1426
Lung Neoplasms
1295
Multiple Myeloma
929
Neoplasm Metastasis
920
Leukemia, Myeloid, Acute
874
Pancreatic Neoplasms
848
Ovarian Neoplasms
799
Melanoma
784
Carcinoma, Hepatocellular
737
Stomach Neoplasms
639
Brain Neoplasms
636
Recurrence
633
Squamous Cell Carcinoma of Head and Neck
632
Head and Neck Neoplasms
609
Glioblastoma
567
Lymphoma
540
Uterine Cervical Neoplasms
539
Triple Negative Breast Neoplasms
505
Precursor Cell Lymphoblastic Leukemia-Lymphoma
499
Carcinoma, Renal Cell
499
Hematologic Neoplasms
463
Urinary Bladder Neoplasms
459
Endometrial Neoplasms
459
Colonic Neoplasms
442
Lymphoma, Non-Hodgkin
436
Sarcoma
434
Interventions
pembrolizumab
1
Platinum
1
Fluorouracil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Solid Neoplasms
×
1 year
×
Clear all
NCT04420884
2026-04-08
iintune-1
Takeda
Phase 1/2
Completed
248 enrolled
NCT07146074
2026-01-20
HERMES
Cancer Research Antwerp
Phase NA
Recruiting
120 enrolled